November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Bone lesions in patients with high risk smoldering myeloma
Nov 9, 2024, 10:50

Bone lesions in patients with high risk smoldering myeloma

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, posted on X about recent paper by Annika Werly et al., titled “Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma” published on Blood Cancer Journal.

Authors: Annika Werly, Mareike Hampel, Thomas Hielscher, Kosima Zuern, Sophia K. Schmidt, Alissa Visram, Marc S. Raab, Carsten Mueller-Tidow, Hartmut Goldschmidt, Elias K. Mai

Bone lesions in patients with high risk smoldering myeloma

“Bone lesions are the mode of progression in ~30% of patients with high risk smoldering myeloma.

Pattern of progression in smoldering myeloma in 447 patients.”

Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group.  He also chairs the Board of directors of  The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee. His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.